Matthew E. Korenberg

Insider Reports History

Entity
Individual
Location
11119 North Torrey Pines Road, Suite 200, La Jolla, CA
Signature
/s/ Kathleen A. McGowan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew E. Korenberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LIGAND PHARMACEUTICALS INC President & COO Common Stock 50.8K $5.18M $102.05 Sep 23, 2024 Direct
LIFECORE BIOMEDICAL, INC. \DE\ Director Common Stock 24.6K $256K $10.42 Aug 19, 2024 Direct
PIERIS PHARMACEUTICALS, INC. CFO, Treasurer Stock Option (right to buy) 167K Dec 13, 2024 Direct
LIGAND PHARMACEUTICALS INC President & COO Employee Stock Option (right to buy) 58.5K Feb 27, 2024 Direct
LIGAND PHARMACEUTICALS INC President & COO Employee Stock Option (right to buy) 42.4K Sep 23, 2024 Direct
Qualigen Therapeutics, Inc. Director Stock Option (Right to Buy) 40K Jul 11, 2022 Direct
LIFECORE BIOMEDICAL, INC. \DE\ Director No Security beneficially owned 0 Aug 15, 2024 Direct

Insider Reports Filed by Matthew E. Korenberg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PVLA PALVELLA THERAPEUTICS, INC. Dec 13, 2024 1 $0 4 Dec 17, 2024 CFO, Treasurer
PVLA PALVELLA THERAPEUTICS, INC. Dec 13, 2024 0 $0 3 Dec 16, 2024 CFO & Treasurer
LGND LIGAND PHARMACEUTICALS INC Sep 20, 2024 10 -$878K 4 Sep 24, 2024 President & COO
LGND LIGAND PHARMACEUTICALS INC Sep 16, 2024 12 $226 4 Sep 18, 2024 President & COO
LGND LIGAND PHARMACEUTICALS INC Aug 22, 2024 5 -$1.99M 4 Aug 26, 2024 President & COO
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Aug 19, 2024 1 $0 4 Aug 21, 2024 Director
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Aug 15, 2024 0 $0 3 Aug 21, 2024 Director
LGND LIGAND PHARMACEUTICALS INC Aug 9, 2024 1 -$1.8M 4 Aug 13, 2024 President & COO
LGND LIGAND PHARMACEUTICALS INC Jun 28, 2024 1 $21.2K 4 Jul 2, 2024 President & Chief Operating
LGND LIGAND PHARMACEUTICALS INC May 13, 2024 3 -$1.5M 4 May 15, 2024 President & Chief Operating
LGND LIGAND PHARMACEUTICALS INC Feb 27, 2024 2 $0 4 Feb 29, 2024 PRESIDENT & CHIEF OPERATING
LGND LIGAND PHARMACEUTICALS INC Feb 15, 2024 1 -$357K 4 Feb 16, 2024 PRESIDENT & CHIEF OPERATING
LGND LIGAND PHARMACEUTICALS INC Jan 2, 2024 1 -$211K 4 Jan 4, 2024 PRESIDENT & CHIEF OPERATING
LGND LIGAND PHARMACEUTICALS INC Dec 5, 2023 1 -$118K 4 Dec 6, 2023 PRESIDENT & CHIEF OPERATING
LGND LIGAND PHARMACEUTICALS INC Jun 30, 2023 1 $21.3K 4 Jul 10, 2023 PRESIDENT & CHIEF OPERATING
LGND LIGAND PHARMACEUTICALS INC Feb 23, 2023 2 $0 4 Feb 27, 2023 President & COO
LGND LIGAND PHARMACEUTICALS INC Feb 15, 2023 1 -$211K 4 Feb 17, 2023 President & COO
LGND LIGAND PHARMACEUTICALS INC Dec 28, 2022 1 -$256K 4 Dec 30, 2022 President & COO
LGND LIGAND PHARMACEUTICALS INC Dec 22, 2022 1 $0 4 Dec 27, 2022 President & COO
LGND LIGAND PHARMACEUTICALS INC Dec 13, 2022 2 $0 4 Dec 15, 2022 President & COO
LGND LIGAND PHARMACEUTICALS INC Nov 30, 2022 1 -$262K 4 Dec 1, 2022 President & COO
LGND LIGAND PHARMACEUTICALS INC Nov 1, 2022 1 $0 4 Nov 3, 2022 President & COO
QLGN Qualigen Therapeutics, Inc. Jul 11, 2022 1 $0 4 Aug 4, 2022 Director
LGND LIGAND PHARMACEUTICALS INC Jun 30, 2022 1 $12.4K 4 Jul 6, 2022 EVP,Finance & Strategy and CFO
LGND LIGAND PHARMACEUTICALS INC Jun 10, 2022 1 $0 4 Jun 14, 2022 EVP,Finance & Strategy and CFO
LGND LIGAND PHARMACEUTICALS INC May 5, 2022 1 $0 4 May 9, 2022 EVP,Finance & Strategy and CFO
LGND LIGAND PHARMACEUTICALS INC Feb 15, 2022 3 -$421K 4 Feb 16, 2022 EVP,Finance & Strategy and CFO
LGND LIGAND PHARMACEUTICALS INC Jan 26, 2022 4 -$412K 4 Jan 28, 2022 EVP,Finance & Strategy and CFO
LGND LIGAND PHARMACEUTICALS INC Jun 30, 2021 1 $21.2K 4 Jul 2, 2021 EVP,Finance & Strategy and CFO